Single-Cell Genome Sequencing Industry - Key Market Dynamics and Trends

The single-cell genome sequencing market size has grown rapidly in recent years. It will grow from $2.17 billion in 2023 to $2.47 billion in 2024 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to increased understanding of genetic heterogeneity, rising demand for precision medicine, increased cancer research, growth in prevalence of infectious diseases, increased healthcare spending.

The single-cell genome sequencing market size is expected to see rapid growth in the next few years. It will grow to $4.27 billion in 2028 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to increasing prevalence of autoimmune diseases, increasing neurological disorders, increasing government initiatives and funding, rise of contract research organizations (cros), increasing awareness of scrna-seq's potential. Major trends in the forecast period include advancements in single-cell sequencing technologies, development of single-cell multi-omics technologies, collaborative initiatives to accelerate advancements, innovative solutions, key players' partnerships.

Market Overview -
Single-cell genome sequencing is a potent method for detecting genomic changes like copy number variations (CNVs) and point mutations and revealing cell-to-cell heterogeneity in biological materials. They are employed to investigate both healthy and diseased physiology.

Download Free Sample of Report -

https://www.thebusinessresearchcompany.com/sample.aspx?id=12655&type=smp

Rising Cancer Prevalence Drives Growth In Single-Cell Genome Sequencing Market
Increasing the prevalence of cancer is expected to propel the growth of the single-cell genome sequencing market going forward. Cancer is a broad category of illnesses where aberrant cells develop and divide out of control. It results from changes in the genes that regulate cell division and control the normal functioning of cells. Cancer is a disease characterized by genetic alterations, and single-cell genome sequencing can help uncover the genetic changes that occur in individual cancer cells. For instance, in January 2023, according to the American Cancer Society, a US-based cancer-fighting organization, there were around 1.9 million new cancer cases and 609,360 cancer deaths in the US in 2022. Further, approximately 27.5 million new cancer cases and 16.3 million cancer deaths are estimated to occur by 2040. Therefore, the increasing prevalence of cancer is expected to propel the growth of the single-cell genome sequencing market.

Competitive Landscape -
Major companies operating in the single-cell genome sequencing market report are F Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., DH Life Sciences LLC., Becton Dickinson And Company (BD), Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Bio-Techne Corporation, BGI Genomics Co. Ltd., Fulgent Genetics Inc., 10x Genomics Inc., Promega Corporation, Takara Bio Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc., Standard BioTools Inc., Singleron Biotechnologies, MGI Tech Co. Ltd, GENEWIZ Inc., Mission Bio Inc., Zymo Research Corporation, Menarini Silicon Biosystems SpA, Novogene Co. Ltd., RareCyte Inc., Fluxion Biosciences Inc., Single Cell Discoveries B.V., Parse Biosciences Inc., BioSpyder Technologies Inc., SeqWell Inc.

Technological Advancements Drive Innovations In Single-Cell Genome Sequencing Market
Technological advancements are a key trend gaining popularity in the single-cell genome sequencing market. Major companies operating in the single-cell genome sequencing market are focused on developing technologically advanced solutions to strengthen their position. For instance, in May 2023, Mission Bio Inc., a US-based single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development, introduced Tapestri Genome Editing Solution, a new end-to-end product for the analysis of genome editing. The novel method is anticipated to serve as a more effective analytical tool for developing next-generation gene-edited drugs by enabling single-cell insights that can change efficacy and safety.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report

Key Segments -

The single-cell genome sequencing market covered in this report is segmented -

1) By Type: Instruments, Reagents
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Quantitative Polymerase Chain Reaction (qPCR), Microarray, Multiple Displacement Amplification (MDA)
3) By Disease Area: Cancer, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology, Other Disease Areas
4) By Application: Circulating Cells, Cell Differentiation Or Reprogramming, Genomic Variation, Subpopulation Characterization, Other Applications
5) By End User: Academic Research Laboratories, Biotechnology Biopharmaceutical Companies, Clinics, Other End Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.